摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (2-chloroethanesulfinyl)acetate | 113207-10-6

中文名称
——
中文别名
——
英文名称
methyl (2-chloroethanesulfinyl)acetate
英文别名
methyl [(2-chloroethyl)sulfinyl]acetate;Methyl2-(2-chloroethylsulfinyl)acetat;methyl 2-(2-chloroethylsulfinyl)acetate
methyl (2-chloroethanesulfinyl)acetate化学式
CAS
113207-10-6
化学式
C5H9ClO3S
mdl
——
分子量
184.644
InChiKey
QCASOZFALSMYCA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    334.0±27.0 °C(Predicted)
  • 密度:
    1.363±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    10
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    62.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (2-chloroethanesulfinyl)acetateDL-高半胱氨酸 在 sodium carbonate 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 49.0h, 生成 2-Amino-4-(2-carboxymethanesulfinyl-ethylsulfanyl)-butyric acid
    参考文献:
    名称:
    S-Alkylated Homocysteine Derivatives:  New Inhibitors of Human Betaine-Homocysteine S-Methyltransferase
    摘要:
    A series of S-alkylated derivatives of homocysteine were synthesized and characterized as inhibitors of human recombinant betaine-homocysteine S-methyltransferase ( BHMT). Some of these compounds inhibit BHMT with IC50 values in the nanomolar range. BHMT is very sensitive to the structure of substituents on the sulfur atom of homocysteine. The S-carboxybutyl and S-carboxypentyl derivatives make the most potent inhibitors, and an additional sulfur atom in the alkyl chain is well tolerated. The respective ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic, ( R, S)-6-( 3-amino-3-carboxy-propylsulfanyl)-hexanoic, and ( R, S)2-amino-4-(2-carboxymethylsulfanyl- ethylsulfanyl)-butyric acids are very potent inhibitors and are the strongest ever reported. We determined that ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic acid displays competitive inhibition with respect to betaine binding with a K-i(app) of 12 nM. Some of these compounds are currently being tested in mice to study the influence of BHMT on the metabolism of sulfur amino acids in vivo.
    DOI:
    10.1021/jm050885v
  • 作为产物:
    描述:
    2-(2-氯乙基巯基)乙酸甲酯盐酸双氧水 作用下, 以56%的产率得到methyl (2-chloroethanesulfinyl)acetate
    参考文献:
    名称:
    S-Alkylated Homocysteine Derivatives:  New Inhibitors of Human Betaine-Homocysteine S-Methyltransferase
    摘要:
    A series of S-alkylated derivatives of homocysteine were synthesized and characterized as inhibitors of human recombinant betaine-homocysteine S-methyltransferase ( BHMT). Some of these compounds inhibit BHMT with IC50 values in the nanomolar range. BHMT is very sensitive to the structure of substituents on the sulfur atom of homocysteine. The S-carboxybutyl and S-carboxypentyl derivatives make the most potent inhibitors, and an additional sulfur atom in the alkyl chain is well tolerated. The respective ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic, ( R, S)-6-( 3-amino-3-carboxy-propylsulfanyl)-hexanoic, and ( R, S)2-amino-4-(2-carboxymethylsulfanyl- ethylsulfanyl)-butyric acids are very potent inhibitors and are the strongest ever reported. We determined that ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic acid displays competitive inhibition with respect to betaine binding with a K-i(app) of 12 nM. Some of these compounds are currently being tested in mice to study the influence of BHMT on the metabolism of sulfur amino acids in vivo.
    DOI:
    10.1021/jm050885v
点击查看最新优质反应信息

文献信息

  • Phenolic thioethers as inhibitors of 5-lipoxygenase
    申请人:G. D. Searle & Co.
    公开号:US04711903A1
    公开(公告)日:1987-12-08
    The compounds of the present invention comprise substituted phenolic thioethers represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different and independently represent tert-alkyl or phenyl; A represents methylene or methylene substituted by alkyl, dialkyl or hydroxy, provided that when A includes hydroxymethylene, the hydroxymethylene group is not adjacent to a heteroatom; B represents sulfur, sulfoxide, sulfone, oxygen, --NH-- or nitrogen substituted by alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl; C represents methylene or methylene substituted by alkyl; R.sub.3 represents CO.sub.2 H, CO.sub.2 -alkyl or a tetrazole group; m is 0 or 1, n is 2, 3 or 4 and p is 1, 2 or 3; amd the pharmaceutically acceptable salts thereof. The compounds of the present invention are specific inhibitors of 5-lipoxygenase and, therefore, are useful in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
    本发明的化合物包括由以下式表示的取代酚硫醚:##STR1##其中:R.sub.1和R.sub.2相同或不同且独立地表示叔烷基或苯基;A表示亚甲基或被烷基、二烷基或羟基取代的亚甲基,但当A包括羟甲基时,羟甲基基团不与杂原子相邻;B表示硫、亚硫氧、砜、氧、--NH--或被烷基、苯基、苄基、取代苯基或取代苄基取代的氮;C表示亚甲基或被烷基取代的亚甲基;R.sub.3表示CO.sub.2 H、CO.sub.2 -烷基或四唑基团;m为0或1,n为2、3或4,p为1、2或3;以及其药学上可接受的盐。本发明的化合物是5-脂氧合酶的特异性抑制剂,因此在治疗局部和全身炎症、过敏和过敏反应以及其他涉及5-脂氧合酶代谢途径中形成的药物的紊乱方面具有用处。
  • Novel phenolic thioethers as inhibitors of 5-lipoxygenase
    申请人:G. D. Searle & Co.
    公开号:US04755524A1
    公开(公告)日:1988-07-05
    The compounds of the present invention comprise substituted phenolic thioethers represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different and independently represent tert-alkyl or phenyl; A represents methylene or methylene substituted by alkyl, dialkyl or hydroxy, provided that when A includes hydroxymethylene, the hydroxymethylene group is not adjacent to a heteroatom; B represents sulfur, sulfoxide, sulfone, oxygen, --NH-- or nitrogen substituted by alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl; C represents methylene or methylene substituted by alkyl; R.sub.3 represents CO.sub.2 H, CO.sub.2 -alkyl or a tetrazole group; m is 0 or 1, n is 2, 3 or 4 and p is 1, 2 or 3; and the pharmaceutically acceptable salts thereof. The compounds of the present invention are specific inhibitors of 5-lipoxygenase and, therefore, are useful in the treatment of local and systemic inflammation, allergy and hypersensitivity reactions and other disorders in which agents formed in the 5-lipoxygenase metabolic pathway are involved.
    本发明的化合物包括由以下式子表示的取代苯基硫醚:##STR1## 其中:R.sub.1和R.sub.2相同或不同,分别表示叔丁基或苯基;A表示亚甲基或被烷基、二烷基或羟基取代的亚甲基,但当A包括羟甲基时,羟甲基基团不与杂原子相邻;B表示硫、亚砜、砜、氧、--NH--或被烷基、苯基、苄基、取代苯基或取代苄基取代的氮;C表示亚甲基或被烷基取代的亚甲基;R.sub.3表示CO.sub.2 H、CO.sub.2 -烷基或四唑基团;m为0或1,n为2、3或4,p为1、2或3;以及其药学上可接受的盐。本发明的化合物是5-脂氧合酶的特异性抑制剂,因此,在治疗局部和全身炎症、过敏和超敏反应以及其他涉及5-脂氧合酶代谢途径中形成的药物时具有用途。
  • <b><i>S</i></b>-Alkylated Homocysteine Derivatives:  New Inhibitors of Human Betaine-Homocysteine <i>S</i>-Methyltransferase
    作者:Jiri Jiracek、Michaela Collinsova、Ivan Rosenberg、Milos Budesinsky、Eva Protivinska、Hana Netusilova、Timothy A. Garrow
    DOI:10.1021/jm050885v
    日期:2006.6.1
    A series of S-alkylated derivatives of homocysteine were synthesized and characterized as inhibitors of human recombinant betaine-homocysteine S-methyltransferase ( BHMT). Some of these compounds inhibit BHMT with IC50 values in the nanomolar range. BHMT is very sensitive to the structure of substituents on the sulfur atom of homocysteine. The S-carboxybutyl and S-carboxypentyl derivatives make the most potent inhibitors, and an additional sulfur atom in the alkyl chain is well tolerated. The respective ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic, ( R, S)-6-( 3-amino-3-carboxy-propylsulfanyl)-hexanoic, and ( R, S)2-amino-4-(2-carboxymethylsulfanyl- ethylsulfanyl)-butyric acids are very potent inhibitors and are the strongest ever reported. We determined that ( R, S)-5-( 3-amino-3-carboxy-propylsulfanyl)-pentanoic acid displays competitive inhibition with respect to betaine binding with a K-i(app) of 12 nM. Some of these compounds are currently being tested in mice to study the influence of BHMT on the metabolism of sulfur amino acids in vivo.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物